Alzheimer’s drug cited as Medicare premium jumps by $21.60

The Biogen Inc., headquarters is shown in Cambridge, Mass. Medicare’s “Part B” outpatient premium will jump by $21.60 next year. Medicare officials told reporters that about half the increase is attributable to contingency planning if the program has to cover Aduhelm, a new $56,000-a-year medication for Alzheimer’s disease made by Biogen. (AP Photo/Steven Senne, File) (Steven Senne/AP)

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *